The addition of oral idarubicin to a chlorambucil/dexamethasone combination has a significant impact on time to treatment failure but none on overall survival in patients with low grade non-Hodgkin's lymphoma: Results of the Scotland and Newcastle Lymphoma Group randomized NHL VIII trial

Dr Penelope Taylor; Dr Brian Angus; Professor Graham Jackson; Dr Helen Lucraft; Professor Stephen Proctor

The addition of oral idarubicin to a chlorambucil/dexamethasone combination has a significant impact on time to treatment failure but none on overall survival in patients with low grade non-Hodgkin's lymphoma: Results of the Scotland and Newcastle Lymphoma Group randomized NHL VIII trial Lookup NU author(s) Dr Penelope Taylor Dr Brian Angus Professor Graham Jackson Dr Helen Lucraft Professor Stephen Proctor



Author(s)		Taylor, P. R. A., White, J. M., Prescott, R. J., Angus, B., Galloway, M. J., Jackson, G. H., Lessells, A. M., Lucraft, H. H., Summerfield, G. P., Proctor, S. J.
Publication type		Article
Journal		Leukemia and Lymphoma
Year		2006
Volume		47
Issue		11
Pages		2321-2330
ISSN (print)		1042-8194
ISSN (electronic)		1029-2403



Full text for this publication is not currently held within this repository. Alternative links are provided below where available.



URL		http://dx.doi.org/10.1080/10428190600881256
DOI		10.1080/10428190600881256
PubMed id		17107904

Actions